or Try an Advanced Search...

    Technical Analysis for VIRI - Virios Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.43 3.87% 0.02
    VIRI closed up 3.87 percent on Wednesday, May 8, 2024, on 35 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    Earnings due: May 9
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical VIRI trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish 3.87%
    50 DMA Resistance Bearish 3.87%
    Bollinger Band Squeeze Range Contraction 3.87%
    Gapped Up Strength 3.87%
    Oversold Stochastic Weakness 3.87%
    50 DMA Resistance Bearish 4.63%
    Older End-of-Day Signals for VIRI ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 12 hours ago
    Up 3% about 12 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    Down 1% about 14 hours ago
    Possible NR7 about 14 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VIRI Chart by TradingView
    Basic chart:

    Profile

    Virios Therapeutics, LLC, a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, LLC in July 2020. Virios Therapeutics, LLC was founded in 2012 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Rheumatology Fibromyalgia Antiviral Therapies

    Is VIRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 2 Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
    Mar 26 Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
    Mar 1 Virios Therapeutics reports Q4 results
    Feb 29 Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
    Feb 28 Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
    Feb 7 VIRI: Moving IMC-2 into Phase 2 Program in Long COVID
    Jan 22 Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge
    Jan 22 Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
    Jan 9 Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Jan 2 Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID
    See more VIRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.42
    52 Week Low 0.279
    Average Volume 325,061
    200-Day Moving Average 0.71
    50-Day Moving Average 0.42
    20-Day Moving Average 0.45
    10-Day Moving Average 0.44
    Average True Range 0.05
    RSI (14) 47.37
    ADX 12.61
    +DI 17.75
    -DI 18.10
    Chandelier Exit (Long, 3 ATRs) 0.39
    Chandelier Exit (Short, 3 ATRs) 0.54
    Upper Bollinger Bands 0.50
    Lower Bollinger Band 0.39
    Percent B (%b) 0.34
    BandWidth 23.09
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0054
    Fundamentals Value
    Market Cap 8.26 Million
    Num Shares 19.3 Million
    EPS -0.16
    Price-to-Earnings (P/E) Ratio -2.68
    Price-to-Sales 0.00
    Price-to-Book 1.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.47
    Resistance 3 (R3) 0.46 0.45 0.46
    Resistance 2 (R2) 0.45 0.44 0.45 0.46
    Resistance 1 (R1) 0.44 0.43 0.44 0.44 0.46
    Pivot Point 0.42 0.42 0.42 0.42 0.42
    Support 1 (S1) 0.41 0.41 0.42 0.42 0.40
    Support 2 (S2) 0.40 0.41 0.40 0.40
    Support 3 (S3) 0.39 0.40 0.40
    Support 4 (S4) 0.39